Administration
The organs of the Finnish Cancer Institute are the Board of Trustees and the Scientific Advisory Board (SAB). The Board of Trustees plans activities and fundraising, decides researcher positions and ensures social impact. Board members are elected for 3 calendar years at a time. The Board consists of six to nine members.
The SAB is composed of a minimum of 6 and a maximum of 15 members nominated by the Board of Trustees. The members of the SAB must be international-level cancer researchers and represent the various aspects of cancer research. The SAB’s task is to monitor the activities of the Finnish Cancer Institute from a scientific point of view and to propose to the Board persons to be appointed as researchers.
Oy Audicon Ab is the Institute’s auditor. Tiina Vesterinen works as the Managing Director.
Board of Trustees 2025:
Tomi Mäkelä (Chair)
Christer Strömberg (Vice-Chair)
Sanna Aunesluoma
Peeter Karihtala
Heikki Lehtonen
Lea Sistonen
Tapio Visakorpi
Scientific Advisory Board 2025:
Päivi Ojala (Chair)
Arto Mannermaa (Vice-Chair)
Steven Bova
Anniina Färkkilä
Sampsa Hautaniemi
Sirpa Jalkanen
Vesa Kataja
Jussi Koivunen
Veli-Matti Kosma
Sirpa Leppä
Janne Pitkäniemi
Ari Ristimäki
Toni Seppälä
Ulla Wartivaara-Kautto
Jukka Westermarck